Department of Otorhinolaryngology-Head and Neck Surgery, Guro Hospital, Korea University College of Medicine, Seoul, South Korea.
Int Forum Allergy Rhinol. 2020 May;10(5):636-645. doi: 10.1002/alr.22525. Epub 2020 Feb 27.
All-trans retinoic acid (ATRA), a derivative of vitamin A, is known to have anti-fibrogenic effects and regulates cell proliferation and differentiation. Therefore, these abilities of ATRA may influence tissue remodeling in the upper airway. The aims of the present study were to investigate the effects of ATRA on the myofibroblast differentiation, extracellular matrix (ECM) production, cell migration, and collagen gel contraction and to determine the molecular mechanisms of ATRA in TGF-β1-induced nasal polyp-derived fibroblasts (NPDFs).
NPDFs were isolated from nasal polyp. Cytotoxicity was evaluated by 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyl-tetrazolium bromide assay. TGF-β1-induced fibroblasts were pretreated with ATRA. The expression levels of alpha-smooth muscle actin (α-SMA), collagen type 1, fibronectin, phospho-mitogen-activated protein kinase, and p-p50 (nuclear factor-kappaB [NF-κB]) were measured by Western blot analysis, real-time polymerase chain reaction, and/or immunofluorescence staining. Cell migration was analyzed with cell migration scratch assay and Transwell migration assay. Collagen contractile activity was measured using a collagen gel contraction assay.
ATRA had no significant cytotoxic effect in NPDFs. Expression levels of α-SMA, collagen type 1, and fibronectin stimulated by TGF-β1 were significantly downregulated in the ATRA-pretreated fibroblasts. TGF-β1-induced cell migration and collagen gel contraction were significantly inhibited by ATRA pretreatment. ATRA also significantly inhibited phosphorylation of c-Jun N-terminal kinase (JNK), p38, and p50 in TGF-β1-induced NPDFs, but did not inhibit phosphorylation of extracellular signal-related kinase (ERK).
ATRA downregulated myofibroblast differentiation, ECM production, cell migration, and collagen gel contraction via p38, JNK-dependent NF-κB-signaling pathways in TGF-β1-induced NPDFs. The findings suggest that ATRA could serve as a novel therapeutic agent to ameliorate nasal polyp development.
全反式维甲酸(ATRA)是维生素 A 的衍生物,已知具有抗纤维化作用,并调节细胞增殖和分化。因此,ATRA 的这些能力可能会影响上呼吸道的组织重塑。本研究旨在探讨 ATRA 对肌成纤维细胞分化、细胞外基质(ECM)产生、细胞迁移和胶原凝胶收缩的影响,并确定 ATRA 在转化生长因子-β1(TGF-β1)诱导的鼻息肉衍生成纤维细胞(NPDF)中的分子机制。
从鼻息肉中分离 NPDF。通过 3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑溴盐法评估细胞毒性。用 ATRA 预处理 TGF-β1 诱导的成纤维细胞。通过 Western blot 分析、实时聚合酶链反应和/或免疫荧光染色检测α-平滑肌肌动蛋白(α-SMA)、胶原 I、纤连蛋白、磷酸化丝裂原活化蛋白激酶和 p-p50(核因子-κB [NF-κB])的表达水平。用细胞迁移划痕试验和 Transwell 迁移试验分析细胞迁移。用胶原凝胶收缩试验测量胶原收缩活性。
ATRA 在 NPDF 中无明显细胞毒性作用。ATRA 预处理可显著下调 TGF-β1 刺激的α-SMA、胶原 I 和纤连蛋白的表达水平。ATRA 预处理还显著抑制 TGF-β1 诱导的细胞迁移和胶原凝胶收缩。ATRA 还显著抑制 TGF-β1 诱导的 NPDF 中 JNK、p38 和 p50 的磷酸化,但不抑制 ERK 的磷酸化。
ATRA 通过 TGF-β1 诱导的 NPDF 中 p38、JNK 依赖性 NF-κB 信号通路下调肌成纤维细胞分化、ECM 产生、细胞迁移和胶原凝胶收缩。研究结果表明,ATRA 可作为一种新的治疗药物,改善鼻息肉的发展。